Pediatrics

CDC recommends RSV shot for all infants

The U.S. Centers for Disease Control and Prevention on Thursday recommended that all infants under the age of 8 months be given a new antibody shot to help guard against severe respiratory syncytial virus (RSV).

Vaccination

GSK sues Pfizer over patents for RSV vaccine

GlaxoSmithKline sued Pfizer on Wednesday over patent infringement, alleging the US drugmaker's RSV vaccine steals key elements of the British company's version.

Diseases, Conditions, Syndromes

Q&A: What's in store for the upcoming respiratory virus season?

Last year's "tripledemic" of flu, COVID-19 and RSV left many of us wary of what the coming respiratory virus season might bring. But this year's landscape is already different, with new vaccines and treatments, like the game-changing ...

Diseases, Conditions, Syndromes

EU drug watchdog approves first RSV infant, elderly vaccine

Europe's drug watchdog on Friday approved the world's first vaccine for infants and those over 60 against the Respiratory Syncytial Virus, a major cause of hospitalization on the continent, the Amsterdam-based agency said.

Diseases, Conditions, Syndromes

The long-awaited RSV vaccine

Two vaccines to protect against respiratory syncytial virus (RSV) are now available for those over age 60, but a vaccine to protect young children is still in development. "The Long-Awaited RSV Vaccine" provides an update ...

Medications

FDA approves new drug to protect against RSV in infants

Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of children under the age of 1 in the United States each year.

Pediatrics

Indigenous children continue to experience high rates of RSV

American Indian/Alaska Native (AI/AN) children experience high rates of respiratory syncytial virus (RSV)-associated acute respiratory illness (ARI) hospitalization, according to a study published online July 14 in Pediatrics.

page 8 from 26